6338
J. Barluenga et al. / Tetrahedron 66 (2010) 6335e6339
(CH), 128.5 (CH), 145.7 (C), 153.7 (C), 156.9 (C), 158.9 (C), 166.2 (C),
166.3 (C). IR (NaCl): 3053, 2987, 1719, 1644, 1421, 1265, 908,
736 cmꢀ1. Elemental analysis calcd for C20H22O5: C, 70.16; H, 6.48;
found: C, 70.28; H, 6.53.
assignable signals are listed): 1H NMR (CDCl3): 1.04 (s, 9H), 2.91 (dd,
J¼17.0, 11.9 Hz, 1H), 3.09e3.17 (m, 1H), 3.10e3.16 (m, 1H), 3.59 (s,
3H), 3.69 (s, 3H), 4.60e4.66 (m, 1H), 5.20 (d, J¼5.1 Hz, 1H), 5.90 (br
s, 1H), 6.28 (d, J¼2.0 Hz, 1H). 13C NMR (CDCl3): 27.8 (CH3), 33.9
(CH2), 38.6 (CH2), 44.1 (CH), 51.1 (CH3), 55.6 (CH3), 110.3 (CH), 116.0
(CH), 117.8 (CH). IR (NaCl): 3053, 2966, 2901, 1713, 1633, 1434, 1265,
1167, 895, 740 cmꢀ1. Elemental analysis calcd for C18H26O5 (mixture
of stereoisomers): C, 67.06; H, 8.13; found C, 67.21; H, 8.19.
3.1.3. (5E,7E)-3-(4-Chlorophenyl)-1-methoxy-5,7-(di(methox-
ycarbonyl)methylen)cyclohept-1-ene (7c). The representative pro-
cedure was followed using 1c (185 mg, 0.50 mmol). After 24 h,
purification by column chromatography (SiO2, hexane/EtOAc, 3:1)
yielded 7c (75 mg, 40%) as a pale yellow oil. 1H NMR (CDCl3): 2.92
(dd, J¼13.7, 11.2 Hz, 1H), 3.52 (s, 3H), 3.61 (dd, J¼13.7, 5.0 Hz, 1H),
3.74e3.92 (2sþm, 8H), 4.31 (d, J¼17.6 Hz, 1H), 4.62 (d, J¼4.6 Hz,
1H), 6.05 (d, J¼1.9 Hz, 1H), 6.09 (s, 1H), 7.29e7.32 (m, 4H). 13C NMR
(CDCl3): 32.7 (CH2), 36.7 (CH2), 42.4 (CH), 51.4 (CH3), 51.5 (CH3),
54.8 (CH3), 99.3 (CH), 115.9 (CH), 116.5 (CH), 128.6 (CH), 128.8 (CH),
132.1 (C), 144.0 (C), 154.2 (C), 156.5 (C), 158.5 (C), 166.1 (C), 166.3
(C). IR (NaCl): 3053, 2986, 1704, 1605, 1442, 1167, 895 cmꢀ1. Ele-
mental analysis calcd for C20H21ClO5: C, 63.75; H, 5.62; found: C,
63.59; H, 5.66.
3.1.7. 3,3-Dimethyl-1-methoxy-5,7-(di(methoxycarbonyl)methylen)
cyclohept-1-ene (7g). The representative procedure was followed
using 1g (145 mg, 0.50 mmol). After 24 h, purification by column
chromatography (SiO2, hexane/EtOAc, 3:1) yielded 7g (45 mg, 31%,
4:1 mixture of stereoisomers) as a colorless oil. Major isomer: 1H
NMR (CDCl3): 1.03 (s, 6H), 2.11 (s, 2H), 2.79 (s, 2H), 3.70 (s, 3H), 3.72
(br s, 6H), 5.55 (s, 1H), 6.13 (s, 1H), 6.84 (s, 1H). 13C NMR (CDCl3):
29.4 (CH3), 38.0 (C), 40.6 (CH2), 44.5 (CH2), 51.1 (CH3), 51.3 (CH3),
55.4 (CH3), 96.1 (CH), 109.8 (CH), 116.9 (CH), 158.3 (C), 159.1 (C),
166.7 (C), 167.2 (C), 167.3 (C). Minor isomer (only clearly assignable
signals are listed): 1H NMR (CDCl3): 1.09 (s, 6H), 2.17 (s, 2H), 2.97 (s,
2H), 3.55 (s, 3H), 3.60 (s, 3H), 5.30 (s, 1H), 5.52 (s, 1H), 5.79 (s, 1H).
13C NMR (CDCl3): 30.1 (CH3), 42.1 (CH2), 45.5 (CH2), 55.6 (CH3), 96.4
(CH). IR (NaCl): 2961, 1710, 1621, 1432, 1139, 895, 737 cmꢀ1. Ele-
mental analysis calcd for C16H22O5 (mixture of stereoisomers): C,
65.29; H, 7.53; found C, 65.15; H, 7.66.
3.1.4. (5E,7E)-3-Ferrocenyl-1-methoxy-5,7-(di(methoxycarbonyl)
methylen)cyclohept-1-ene (7d). The representative procedure was
followed using 1d (223 mg, 0.50 mmol). After 16 h, purification by
column chromatography (SiO2, hexane/EtOAc, 3:1) yielded 7d
(126 mg, 56%) as a pale red viscous oil. 1H NMR (CDCl3): 2.95 (dd,
J¼15.6, 12.5 Hz, 1H), 3.50e3.62 (sþm, 6H), 3.76 (s, 3H), 3.77 (s, 3H),
4.11e4.19 (sþm, 9H), 4.26 (d, J¼18.0,1H), 4.85 (d, J¼4.3 Hz,1H), 5.98
(br s, 2H). 13C NMR (CDCl3): 33.4 (CH2), 35.5 (CH), 37.2 (CH2), 51.3
(CH3), 51.4 (CH3), 54.6 (CH3), 66.7 (CH), 66.8 (CH), 67.2 (CH), 67.5
(CH), 68.5 (CH), 93.9 (C),100.9 (CH),115.9 (CH),116.4 (CH),153.0 (C),
157.2 (C), 159.5 (C), 166.2 (C), 166.3 (C). IR (NaCl): 3053, 2986, 1713,
1633, 1422, 1265, 1166, 895, 738 cmꢀ1. Elemental analysis calcd for
C24H26FeO5: C, 64.01; H, 5.82; found C, 63.95; H, 5.86.
Acknowledgements
We are grateful to the Ministerio de Ciencia e Innovación
(MICINN) of Spain (Grant CTQ-2007-61048) and the Principado de
Asturias (Grant IB 08-088). R.V. thanks the MICINN for a Juan de la
Cierva contract. We are also grateful to Dr. César J. Pastor (SIdI,
Universidad Autónoma de Madrid) for his assistance in the collec-
tion of the X-ray data.
3.1.5. 3-n-Butyl-1-methoxy-5,7-(di(methoxycarbonyl)methylen) cy-
clohept-1-ene (7e). The representative procedure was followed
using 1e (159 mg, 0.50 mmol). After 24 h, purification by column
chromatography (SiO2, hexane/EtOAc, 3:1) yielded 7e (63 mg, 39%,
3:1 mixture of stereoisomers) as a colorless oil. Major isomer: 1H
NMR (CDCl3): 0.88e0.94 (m, 3H), 1.32e1.63 (m, 6H), 2.43e2.46 (m,
1H), 2.76e2.84 (m, 1H), 3.06e3.25 (m, 2H), 3.46 (s, 3H), 3.71 (s, 3H),
3.72 (s, 3H), 4.15 (d, J¼17.8 Hz, 1H), 4.46 (d, J¼5.2 Hz, 1H), 5.91 (s,
2H). 13C NMR (CDCl3): 14.1 (CH3), 22.8 (CH2), 29.2 (CH2), 33.8 (CH2),
35.0 (CH), 35.7 (CH2), 36.9 (CH2), 51.2 (CH3), 51.4 (CH3), 54.5 (CH3),
101.2 (CH), 115.7 (CH), 116.2 (CH), 153.3 (C), 157.9 (C), 161.1 (C), 166.2
(C), 166.5 (C). Minor isomer (only clearly assignable signals are lis-
ted): 1H NMR (CDCl3): 2.62e2.66 (m,1H), 3.06e3.10 (m,1H), 3.56 (s,
3H), 3.67 (s, 3H), 4.61 (d, J¼14.3 Hz, 1H), 5.02 (d, J¼4.1 Hz, 1H), 5.94
(br s, 1H), 6.27 (s, 1H). 13C NMR (CDCl3): 13.9 (CH3), 29.4 (CH2), 33.7
(CH), 37.0 (CH2), 37.6 (CH2), 38.6 (CH2), 50.8 (CH3), 55.2 (CH3), 113.6
(CH), 115.4 (CH), 117.0 (CH), 149.7 (C), 153.2 (C), 159.6 (C), 166.9 (C),
167.4 (C). IR (NaCl): 2953, 2930, 2872, 1716, 1634, 1456, 1378, 1195,
1171, 906, 729, 650 cmꢀ1. Elemental analysis calcd for C18H26O5
(mixture of stereoisomers): C, 67.06; H, 8.13; found C, 67.01; H, 8.25.
Supplementary data
Supplementary data associated with this article can be found in
References and notes
1. For recent reviews on Fischer carbene complexes, see: (a) Wulff, W. D. In
Comprehensive Organometallic Chemistry II; Abel, E. W., Stone, F. G. A., Wilkin-
son, G., Eds.; Pergamon: New York, NY, 1995; Vol. 12; (b) Herndon, J. W. Tet-
rahedron 2000, 56, 1257; (c) Barluenga, J.; Fañanás, F. J. Tetrahedron 2000, 56,
4597; (d) Sierra, M. A. Chem. Rev. 2000, 100, 3591; (e) de Meijere, A.; Schirmer,
H.; Duestch, M. Angew. Chem., Int. Ed. 2000, 39, 3964; (f) Barluenga, J.; Santa-
maría, J.; Tomás, M. Chem. Rev. 2004, 104, 2259; (g) Barluenga, J.; Fernández-
€
Rodríguez, M. A.; Aguilar, E. J. Organomet. Chem. 2005, 690, 539; (h) Dotz, K. H.;
Stendel, J., Jr. Chem. Rev. 2009, 109, 3227.
2. For Cr/Pd or W/Pd exchange, see: (a) Sierra, M. A.; Mancheño, M. J.; Sáez, E.; del
Amo, J. C. J. Am. Chem. Soc. 1998, 120, 6212; (b) Sierra, M. A.; del Amo, J. C.;
Mancheño, M. J.; Gómez-Gallego, M. J. Am. Chem. Soc. 2001, 123, 851; (c) Al-
béniz, A. C.; Espinet, P.; Manrique, R.; Pérez-Mateo, A. Angew. Chem., Int. Ed.
2002, 41, 2363; (d) López-Alberca, M.; Mancheño, M. J.; Fernández, I.; Gómez-
Gallego, M.; Sierra, M. A.; Torres, R. Org. Lett. 2007, 9, 1757 For Cr/Rh exchange,
€
€
see: (e) Aumann, R.; Gottker-Schnetmann, I.; Frohlich, R.; Meyer, O. Eur. J. Org.
€
Chem. 1999, 2545; (f) Gottker-Schnetmann, I.; Aumann, R. Organometallics
3.1.6. 3-tert-Butyl-1-methoxy-5,7-(di(methoxycarbonyl)methylen)
cyclohept-1-ene (7f). The representative procedure was followed
using 1f (159 mg, 0.50 mmol). After 24 h, purification by column
chromatography (SiO2, hexane/EtOAc, 4:1) yielded 7f (76 mg, 47%,
5:1 mixture of stereoisomers) as a colorless oil. Major isomer: 1H
NMR (CDCl3): 1.03 (s, 9H), 2.33e2.47 (m,1H), 2.53 (t, J¼12.0 Hz,1H),
3.35e3.44 (mþs, 5H), 3.71 (s, 3H), 3.72 (s, 3H), 4.22 (d, J¼18 Hz,1H),
4.55 (d, J¼5.6 Hz, 1H), 5.91e5.93 (m, 2H). 13C NMR (CDCl3): 27.2
(CH3), 30.8 (CH2), 33.2 (CH2), 34.4 (C), 46.2 (CH), 51.2 (CH3), 51.4
(CH3), 54.4 (CH3), 97.8 (CH), 114.9 (CH), 116.3 (CH), 153.6 (C), 158.6
(C), 161.1 (C), 166.3 (C), 166.4 (C). Minor isomer (only clearly
€
2001, 20, 346; (g) Gottker-Schnetmann, I.; Aumann, R. Organometallics 2001,
€
20, 3574 For Cr/Cu exchange, see: (h) Barluenga, J.; López, L. A.; Lober, O.;
Tomás, M.; García-Granda, S.; Álvarez-Rúa, C.; Borge, J. Angew. Chem., Int. Ed.
2001, 40, 3392 For Cr/Ni exhange, see: (i) Barluenga, J.; Barrio, P.; López, L. A.;
Tomás, M.; García-Granda, S.; Álvarez-Rúa, C. Angew. Chem., Int. Ed. 2003, 42,
3008; (j) Barluenga, J.; Barrio, P.; Riesgo, L.; López, L. A.; Tomás, M. J. Am. Chem.
Soc. 2007, 129, 14422 For a review on transmetallation in Fischer carbene
complexes, see: (k) Sierra, M. A.; Mancheño, M. J.; Gómez-Gallego, M. Acc.
Chem. Res. 2005, 37, 44.
3. (a) Barluenga, J.; Vicente, R.; López, L. A.; Rubio, E.; Tomás, M.; Álvarez-Rúa, C. J.
Am. Chem. Soc. 2004, 126, 470; (b) Barluenga, J.; Vicente, R.; López, L. A.; Tomás,
M. J. Organomet. Chem. 2006, 691, 5654.
4. For recent reviews on synthetic applications of allenes, see: (a) Modern Allene
Chemistry; Krause, N., Hashmi, A. S. K., Eds.; Wiley-VCH: Weinheim, 2004; Vols.